New Ebola Vaccines Under Development Amid Outbreak Fears
Three new Ebola vaccines are in the works as fears grow over a potential outbreak. With nearly 250 deaths reported, the urgency for effective solutions has never been higher.
Urgent Vaccine Development
As the Ebola outbreak escalates, three promising vaccines are being developed to combat the Bundibugyo species, which has already claimed nearly 250 lives. The International Aids Vaccine Initiative (IAVI) is leading one of the efforts, emphasizing that this outbreak could rival the devastating epidemic of 2014-2016.
Currently, there are over 1,000 suspected cases in the Democratic Republic of Congo, with nine confirmed cases in Uganda. The Coalition for Epidemic Preparedness Innovations (Cepi) is funding these initiatives, stressing that "every day counts" in the race to develop effective vaccines.
- Key points about the outbreak and vaccine development:
- The Bundibugyo species has only been seen twice before.
- IAVI's modified Zaire Ebola vaccine shows promising results in monkeys.
- Moderna is leveraging mRNA technology to expedite vaccine development.
- The University of Oxford is also working on a new vaccine, expected to enter clinical trials soon.